ALSN Vol. 9, No. 2
Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Posted on Sunday, February 1, 2004 - 07:00, By: ALSN Staff
Study of new compound open
The international pharmaceutical company Novartis has opened a large-scale, dose-finding trial of a compound called TCH346 for treatment of ALS.
Voice synthesis study advances
Posted on Sunday, February 1, 2004 - 07:00, By: Margaret Wahl
The first phase of a project whose goal is to allow people with ALS and similar conditions to "speak" through a computer in their own voices has come to a successful completion, says investigator Tim Bunnell...